Frequency and anatomical distribution of urinary tract stones in patients presenting to institute of kidney diseases (IKD) Peshawar
DOI:
https://doi.org/10.59736/IJP.24.03.1118Keywords:
Kidney Calculi, Urolithiasis, Ureteral Calculi, Urinary Tract Calculi.Abstract
Background: Urinary tract stones (UTS) is a prevalent urological issue and an important source of morbidity across the globe. Dietary fluctuations, sedentary habits, metabolic diseases, obesity and environmental influence have augmented its overload. Positioning of the stone influences the symptoms, diagnosis, therapy and prognosis. There is limited local data concerning stone location in Pakistan. The purpose of this study was to establish the prevalence and distribution of urinary tract stones in hospital patients.
Methods: It is a cross-sectional study that was done at the Institute of Kidney Diseases (IKD), Peshawar, during the period May to July 2026. Two hundred and six patients who had a urinary stone that had been radiologically proven were included. There was the recording of demographic, clinical, imaging, and stone location and risk factor. The SPSS 26 was used to analyze the data, which were presented as means in SDs, frequencies, and percentages.
Results: 206 patients were studied with a mean of 42.7±13.5 years and 64.1 percent men. Most common were renal and ureteric stones. The most frequent ones were lower calyceal and lower ureteric stones. The majority of stones were unilateral. Risk factors were low levels of fluid intake and high salt intake.
Conclusion: Urinary stones were predominant in middle-aged males with the predominant location renal and ureteric. Local stone patterns could assist in enhancing the diagnosis, treatment, and prevention.
References
Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project. Eur Urol. 2002;42(4):323-8.
Thomas K, Chow K, Kirby R. Acute urinary retention: a review of the etiology and management. Prostate Cancer Prostatic Dis 2004;7(1):32-7.
https://doi.org/10.1038/sj.pcan.4500700
Nitti VW. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005;7(Suppl 6): S14-21
Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005;7 Suppl 9(Suppl 9):S3-s14.
Frendl DM, Chou WH, Chen YW, Chang DC, Kim MM. Early vs Delayed Transurethral Surgery in Acute Urinary Retention: Does Timing Make a Difference? J Urol. 2023;210(3):492-9.
Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia - what do we know? BJU Int. 2021;127(4):389-99.
Yoon PD, Chalasani V, Woo HH. Systematic review and meta-analysis on management of acute urinary retention. Prostate Cancer Prostatic Dis. 2015;18(4):297-302.
Fitzpatrick JM, Kirby RS. Management of acute urinary retention. BJU Int. 2006;97 Suppl 2:16-20; discussion 1-2.
Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez Guerra L, Hong SJ, El Khalid S, et al. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int. 2012;109(1):88-95.
Uroos SU, Anwer M, Noor S, Rashid M. A comparative study of Silodosin vs. Tamsulosin in the management of Benign Prostatic Hyperplasia: Outcomes in a tertiary care setting in Karachi. Int. j. endorsing health sci. res. 2024;12(4):222-8.
Gwon YN, Park JJ, Yang WJ, Doo SW, Kim JH, Kim DK. Comparing effects of alpha-blocker management on acute urinary retention secondary to benign prostatic hyperplasia: A systematic review and network meta-analysis. Prostate Int. 2023;11(2):91-9.
Ahmed M. The role of sustained-released alfuzosin in the treatment of acute urinary retention. Med J Tikrit Univ 2012;18(2):67-72.
Ahmed G, Murtaza B, Ahmed U, Khan AY, Akhtar MT, Shahid MF. Comparison of Tamsulosin and Silodosin in the Management of Acute Urinary Retention Secondary to Benign Prostatic Enlargement. Pak Armed Forces Med J. 2025;75:S1149-S53
Denimal L, Klein C, Capon G, Alezra E, Bernhard JC, Estrade V, et al. Impact of clean intermittent self-catheterization and indwelling catheterization on perioperative outcomes in patients with urinary retention undergoing BPH surgery: A comparative monocentric retrospective study. Fr J Urol. 2025;35(1):102851.
Fusco F, Palmieri A, Ficarra V, Giannarini G, Novara G, Longo N, et al. α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies. Eur Urol. 2016;69(6):1091-101.
Patil SB, Ranka K, Kundargi VS, Guru N. Comparison of tamsulosin and silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia in patients planned for trial without catheter. A prospective randomized study. Cent European J Urol. 2017;70(3):259.
Hassan HU, Gazder TA, Khan N, Jafri A, Hassan AS, Hashmi A. Comparative effectiveness of silodosin vs. tamsulosin in treating acute urinary retention in benign prostatic hyperplasia patients. J Pak Med Assoc. 2025;75(4):592-5
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ikram Ullah, Shabir Hasan, Misbah Ur Rahman, Wajahat Ullah, Syed Sheraz Ali, Sajjad Muhammad Khan Shinwari
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
